Condensed Consolidated Statements of Operations - USD ($)	12 Months Ended
Dec. 31, 2020	Dec. 31, 2019
Revenues [Abstract]
Revenue - related party	$ 40,000	$ 24,000
Operating Expenses
Research and development	114,559	218,919
General and administrative	323,806	217,510
Total Operating Expenses	438,365	436,429
Loss from Operations	(398,365)	(412,429)
Other Expenses
Loss on impairment	0	(69,178)
Interest expense	(135,295)	(33,309)
Total Other Expenses	(135,295)	(102,487)
Loss before Income Taxes	(533,660)	(514,916)
Provision for Income Taxes	0	0
Net Loss	$ (533,660)	$ (514,916)
Net Loss per Share - Basic and Diluted	$ (0.01)	$ (0.02)
Weighted Average Common Shares Outstanding - Basic and Diluted	30,742,649	31,750,106

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256